Search
Mission
Page
target, and drug to combat infectious disease. A portrait of HIRI and its managing director Prof Jörg Vogel (in German). Our major goals are To better understand infections at the single-cell level To detect
ASOBIOTICS 2024
Page
dynamics and function of these proteases. Further information Jörg Vogel - Helmholtz Institute Würzburg (HIRI), DE Jörg Vogel © Nik Schölzel Jörg Vogel's research group at the Helmholtz Institute Würzburg in [...] n2.png Nadja Patenge © Anita Thamm…
” She was also lucky when looking for a job: “I had my first and only interview in Germany with Jörg Vogel, and he offered me a position.” Dynamic growth In 2018, Achmedov transferred from the University [...] the other. RNA Society Spotlights HIRI…
Papadopoulos © privat Karl Petri © JMU / Daniel Peter Jörg Vogel Jörg Vogel © Nik Schölzel RNA Biology of Bacterial Infections The research group led by Jörg Vogel investigates the RNA world of microbes during [...] drug, and therapeutic target for…
of Würzburg, Prof Dr Paul Pauli. Thereafter, the spokesperson of the RNA med program, Prof Dr Jörg Vogel, gave a comprehensive overview of the objectives, milestones and ongoing progress of RNA med .
Würzburg Institute of Systems Immunology (WüSI). Spokesperson of the Single-Cell Center is Prof Jörg Vogel, the Managing Director of the HIRI. The center’s objective is to analyze and understand diseases
she has demonstrated her excellence in the field of molecular infection research," HIRI Director Jörg Vogel acknowledged the molecular biologist, who has been conducting research at HIRI since 2018. By awarding
Date:
Oct 16th 2023 09:00
- Oct 20th 2023 12:20
Location: Würzburg, Germany
Location: Würzburg, Germany
09:15 – 10:10 RNA as a biomolecule (Claudia Höbartner) 10:20 – 11:15 Regulatory RNAs in bacteria (Jörg Vogel) 11:25 – 12:20 Regulatory RNAs in eukaryotes (Mathias Munschauer) 12:20 – 12:30 Day wrap up (Redmond
Date:
May 8th 2019 09:00
- May 10th 2019 16:30
Location: Würzburg, Germany
Location: Würzburg, Germany
45-13.30 Lunch break 13.30-14.25 Phage therapy (Chase Beisel) 14.30-15.25 RNA-based therapeutics (Jörg Vogel) 15.25-15.40 Coffee break 15.45-16.30 High-throughput screening (Ana Rita Brochado) 16.30-16.35
the other. RNA Society Spotlights HIRI Director 23.02.2023 This month, the RNA Society profiled Jörg Vogel. Read about his career path, his advice on how to succeed in science, and his favorite RNA Load